Drug Trial Radar · NCT00441246
Phase 4 Study - Mucinex D as Adjunct Therapy
Last checked: Nov 20, 2026Latest source record: Feb 6, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
600
Planned (sponsor's estimate)
Start
Feb 2007
Primary completion
May 2007
Study completion Jul 2007
Sponsor
- Lead sponsor
- Adams Respiratory TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 28, 2007
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.
Conditions
- Acute Respiratory Infection
- Bronchitis
- Rhinosinusitis
Interventions
Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.Time frame: 7 days
Locations
28 sites in 1 country. Site status is shown where the registry gives one.
Alabama Clinical Therapuetics, LLC, 52 Medical Park East Drive, Suite 214
Birmingham, Alabama
MedCenter, 6651 Madison Ave.
Carmichael, California
Torrance Clinical Research, 3640 Lomita Blfd #205
Torrance, California
Clinicos, LLC
Colorado Springs, Colorado
Longmont Clinic, P.C., 1925 W. Mountain View Ave.
Longmont, Colorado
Front Range Clinical Research
Wheat Ridge, Colorado
Dawsonville Family Medicine Clinical Trials, 5983 Hwy, 53E. Ste 175
Dawsonville, Georgia
Koch Family Medicine, 81A E. Queenwood Rd.
Morton, Illinois
Welborn Clinic Gateway, 4233 Gateway Blvd
Newburgh, Indiana
Sterling Research Group, Ltd., 650 Sprucewood Lane
Erlanger, Kentucky
Columbia Medical Practice, 3450 Knoll Dr. North #200C
Columbia, Maryland
Clinical Associates, 750 Main St. #201
Reisterstown, Maryland
Milford Emergency Associates, Inc., 14 Asylum St.
Milford, Massachusetts
Michigan Institute of Medicine, 38525 Eight Mile Rd.
Livonia, Michigan
Central Nebraska Medical Clinic, PC, 145 Memorial Drive
Broken Bow, Nebraska
Immedicenter, 557 Broad St.
Bloomfield, New Jersey
Central New York Clinical Research, RT 92, The Market Place
Manlius, New York
North Carolina Clinical Research, 4301 Lake Boone Trail, Ste 309-A
Raleigh, North Carolina
DayStar Clinical Research, Inc., 880 Mull Ave., Suite 100
Akron, Ohio
DataPharm, Inc., 6715 Tippecanoe Rd., Bldg E (LL)
Canfield, Ohio
Parsons Avenue Medical Clinic, 1493 Parsons Avenue
Columbus, Ohio
Blair Medical Associates, Inc., Station Medical Center, 1414 Ninth Ave.
Altoona, Pennsylvania
Harleysville Medical Associates, 176 Main Street
Harleysville, Pennsylvania
Lederach Family Medicine, PC, 658 Harleysville Pike, Suite 120
Harleysville, Pennsylvania
Greentree Medical Associates, 651 Holiday Drive, Foster Plaza Bldg #5
Pittsburgh, Pennsylvania
MetaClin Research, Inc., 6012 West William Cannon Drive, 6012 West William Cannon Drive
Austin, Texas
Apollo Research Institute, 117 Dilworth Plaza
Poth, Texas
Advanced Clinical Research, Inc., 3590 West 9000 South, Suite 230
West Jordan, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.